ADA2017

News

Novo hopes data will boost new insulin in US and Germany

Novo Nordisk hopes that new data supporting the cardiovascular and glycaemic safety of its Tresiba long-acting insulin will prove a game-changer in the US.

News

Sanofi/Regeneron PCSK9 lowers cholesterol in diabetes patien...

Companies awaiting CV outcomes trial, and court decision in patent case

News

Senate could back Trump health law by 4th July, despite warn...

Reforms could take away health insurance from 23 million, and deny insurance to those with pre-existing conditions, such as diabetes

News

ADA to re-evaluate tweet ban after backlash

ADA says photo ban is to protect intellectual property.

Novo hopes data will boost new insulin in US and Germany

Sanofi/Regeneron PCSK9 lowers cholesterol in diabetes patien...

Senate could back Trump health law by 4th July, despite warn...

ADA to re-evaluate tweet ban after backlash

UK partners with Eli Lilly on obesity plan

Discover a new era of healthcare panel engagement: Grounded ...

ADA2017

Editor's Picks